A randomized controlled clinical trial of topical insulin-like growth factor-1 therapy for sudden deafness refractory to systemic corticosteroid treatment

BACKGROUND: To date, no therapeutic option has been established for sudden deafness refractory to systemic corticosteroids. This study aimed to examine the efficacy and safety of topical insulin-like growth factor-1 (IGF-1) therapy in comparison to intratympanic corticosteroid therapy. METHODS: We r...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakagawa, Takayuki, Kumakawa, Kozo, Usami, Shin-ichi, Hato, Naohito, Tabuchi, Keiji, Takahashi, Mariko, Fujiwara, Keizo, Sasaki, Akira, Komune, Shizuo, Sakamoto, Tatsunori, Hiraumi, Harukazu, Yamamoto, Norio, Tanaka, Shiro, Tada, Harue, Yamamoto, Michio, Yonezawa, Atsushi, Ito-Ihara, Toshiko, Ikeda, Takafumi, Shimizu, Akira, Tabata, Yasuhiko, Ito, Juichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236431/
https://www.ncbi.nlm.nih.gov/pubmed/25406953
http://dx.doi.org/10.1186/s12916-014-0219-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236431/
https://www.ncbi.nlm.nih.gov/pubmed/25406953
http://dx.doi.org/10.1186/s12916-014-0219-x

Ejemplares similares